Conduit Pharmaceuticals logo

Conduit Pharmaceuticals Share Price (NASDAQ: CDT)

$1.41

-0.14

(-9.03%)

Last updated on

Check the interactive Conduit Pharmaceuticals Stock chart to analyse performance

Conduit Pharmaceuticals stock performance

as on August 28, 2025 at 11:31 pm IST

  • Today's Low:$1.41
    Today's High:$1.50

    Day's Volatility :6.0%

  • 52 Weeks Low:$1.40
    52 Weeks High:$274.80

    52 Weeks Volatility :99.49%

Conduit Pharmaceuticals Stock Returns

PeriodConduit Pharmaceuticals IncIndex (Russel 2000)
3 Months
-60.5%
0.0%
6 Months
-91.49%
0.0%
1 Year
-99.34%
0.0%
3 Years
-99.99%
-6.9%

Conduit Pharmaceuticals Inc Key Stats

Check Conduit Pharmaceuticals key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$1.43
Open
$1.5
Today's High
$1.405
Today's Low
$1.37
Market Capitalization
$4.7M
Today's Volume
$177.0K
52 Week High
$274.8
52 Week Low
$1.4
Revenue TTM
$0.0
EBITDA
$-15.0M
Earnings Per Share (EPS)
$-142.21
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
0.0%

Stock Returns calculator for Conduit Pharmaceuticals Stock including INR - Dollar returns

The Conduit Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Conduit Pharmaceuticals investment value today

Current value as on today

₹5,009

Returns

₹94,991

(-94.99%)

Returns from Conduit Pharmaceuticals Stock

₹99,351 (-99.35%)

Dollar Returns*

₹4,360 (+4.36%)

Indian investors sentiment towards Conduit Pharmaceuticals Stock

32%

Period: Jul 28, 2025 to Aug 27, 2025. Change in 30 Days versus previous period

Search interest for Conduit Pharmaceuticals Stock from India on INDmoney has increased by 32% in the last 30 days, reflecting an upward trend in search activity.

Analyst Recommendation on Conduit Pharmaceuticals Stock

Rating
Trend

Conduit Pharmaceuticals Stock Insights

  • Price Movement

    In the last 7 days, CDT stock has moved down by -7.1%
  • CDT vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 61.8% return, outperforming this stock by 161.1%

Conduit Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Conduit Pharmaceuticals is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Conduit Pharmaceuticals Inc Vs Peers

Returns
Ratio's
Overview
Company Name1 Month6 Month1 Year3 Years5 Years
Conduit Pharmaceuticals Inc logo
-23.94%
-91.49%
-99.34%
-99.99%
-99.99%
Regeneron Pharmaceuticals, Inc. logo
5.16%
-16.48%
-51.06%
-0.98%
-5.32%
Beone Medicines Ltd logo
-1.83%
7.82%
51.46%
79.4%
24.25%
Vertex Pharmaceuticals Incorporated logo
-16.94%
-18.0%
-20.55%
38.17%
39.4%
Alnylam Pharmaceuticals, Inc. logo
37.4%
91.56%
61.8%
117.28%
242.42%

About Conduit Pharmaceuticals Inc

CDT Equity Inc., a clinical-stage specialty biopharmaceutical company, develops pharmaceutical products that provides unmet medical needs in the areas of autoimmune diseases and idiopathic male infertility. Its pipeline includes AZD1656, which has completed Phase I trials for the treatment of type 2 diabetes, renal transplant, Hashimoto's thyroiditis, uveitis, and preterm labor; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility. It has strategic services agreement with formulation development CDMO Agility Life Sciences to develop new solid oral-dosage form products. The company was formerly known as Conduit Pharmaceuticals Inc. and changed its name to CDT Equity Inc. in August 2025. The company was founded in 2019 and is based in Naples, Florida.
Organization
Conduit Pharmaceuticals
Employees
6
CEO
Mr. James Bligh
Industry
Miscellaneous

Key Management of Conduit Pharmaceuticals Inc

NameTitle
Mr. James Bligh
Co-Founder, CFO & Director

Important FAQs about investing in CDT Stock from India :

What is Conduit Pharmaceuticals share price today?

Conduit Pharmaceuticals share price today is $1.41 as on at the close of the market. Conduit Pharmaceuticals share today touched a day high of $1.50 and a low of $1.41.

What is the 52 week high and 52 week low for Conduit Pharmaceuticals share?

Conduit Pharmaceuticals share touched a 52 week high of $274.80 and a 52 week low of $1.40. Conduit Pharmaceuticals stock price today i.e. is closed at $1.41, lower by 99.49% versus the 52 week high.

How to invest in Conduit Pharmaceuticals Stock (CDT) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Conduit Pharmaceuticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Conduit Pharmaceuticals Shares that will get you 1.0638 shares as per Conduit Pharmaceuticals share price of $1.41 per share as on August 28, 2025 at 11:31 pm IST.

What is the minimum amount required to buy Conduit Pharmaceuticals Stock (CDT) from India?

Indian investors can start investing in Conduit Pharmaceuticals (CDT) shares with as little as ₹87.587 or $1 (as of August 28, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹875.87 in Conduit Pharmaceuticals stock (as per the Rupee-Dollar exchange rate as on August 28, 2025). Based on Conduit Pharmaceuticals share’s latest price of $1.41 as on August 28, 2025 at 11:31 pm IST, you will get 7.0922 shares of Conduit Pharmaceuticals. Learn more about fractional shares .

What are the returns that Conduit Pharmaceuticals has given to Indian investors in the last 5 years?

Conduit Pharmaceuticals stock has given -99.99% share price returns and 18.52% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?